#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial encephalomyopathy Bronchopulmonary dysplasia T-cell type acute leukaemia Lung adenocarcinoma Systemic lupus erythematosus Plasma cell myeloma Cervix carcinoma recurrent Thyroid cancer metastatic Soft tissue sarcoma Liposarcoma Obliterative bronchiolitis Rhabdomyosarcoma recurrent Neurofibromatosis Hepato-lenticular degeneration Angiosarcoma recurrent More trials…

    Learn about Rare Diseases

    Noonan syndrome – Diagnostics Angiosarcoma non-metastatic Hairy cell leukaemia – Diagnostics Niemann-Pick disease – Diagnostics Uterine leiomyosarcoma – Trials in Disease Hereditary neuropathic amyloidosis – Diagnostics Gaucher’s disease type III Chondrosarcoma metastatic – Diagnostics Breast angiosarcoma Angiosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inotuzumab Ozogamicin Co-Trimoxazole Felzartamab Burfiralimab LIGUFALIMAB Metyrapone Bp Odm-208 Rivaroxaban Padeliporfin Olmesartan Medoxomil Saxagliptin OSIMERTINIB MESYLATE Pivmecillinam Hydrochloride Upacicalcet Sodium Hydrate Lonapegsomatropin Gs-5245 Hydrocortisone Hemisuccinate Amb-05X Thiopental Sodium Artemisia Vulgaris (312) More therapies…

    Learn about Your Condition

    Peripheral artery angioplasty Underweight Oesophageal disorder Ischaemic stroke Biliary neoplasm Metastases to peritoneum Hypomagnesaemia Acute HIV infection Chronic sinusitis KBG syndrome Gestational diabetes Rhabdomyosarcoma recurrent Basal cell carcinoma Mixed dementia Lung transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute coronary syndrome

  • Study on Metformin’s Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome

    Not yet recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Metformin Hydrochloride
    Poland
  • Reduced Dose Prasugrel Monotherapy After Stent Placement in Patients with Acute and Chronic Coronary Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    The Netherlands
  • Study on Monitoring Anticoagulant Therapy with Rivaroxaban and Warfarin in Patients with Acute Coronary Syndrome and Atrial Fibrillation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Atrial fibrillation
    Investigated Drugs:
    • Rivaroxaban
    • Warfarin Sodium
    France
  • Study on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    Poland
  • Study on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Poland
  • Study Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    The Netherlands
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!